靶向于多发性骨髓瘤细胞和骨髓微环境的治疗进展
被引量：1
出处
《重庆医学》
CAS
CSCD
2008年第20期2358-2361,共4页
Chongqing medicine
基金
国家自然科学基金资助项目(30772520)
参考文献26
-
1Li ZW, William SD. Tumor microenvironment and drug resistance in hematologic malignancies [J ]. Blood Reviews, 2006,20 :333.
-
2Schmidmaier R, Morsdorf K, Baumann P, et al. Evidence for cell adhesion mediated drug resistance of multiple myeloma cells in vivo [J]. International J Biolog Marke, 2006,21(4) :218.
-
3Pagnucco G, Cardinale G, Gervasi F. Targeting multiple myeloma cells and their bone marrow microenvironment [J]. Ann N Y Acad Sci,2004,1028:390.
-
4Wagner W,Wein F,Roderburg C,et al. Adhesion of hematopoietie progenitor cells to human mesenchymal stem cells as a model for cell cell interaction[J]. Exp Hematol, 2007,35(2):314.
-
5Stephanie RW, Martin MO, Kathryn LL, et al. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients[J]. Cancer,2001,91(7) : 1219.
-
6Tai YT, Li XF, Breitkreutz I, et al. Role of B-cell-activa ting factor in adhesion and growth of human multiple my eloma cells in the bone marrow microenvironment[J]. Cancer Res,2006,66(13) :6675.
-
7Calabro A,Oken MM, Hascall VC, et al. Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenehymal progenitor cells:predominant expression of HAS1 mRNA and up regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients[J]. Blood, 2002,100 (7) : 2578.
-
8Landowski TH, Olashaw NE, Agrawal D,et al. Cell adhesion mediated drug resistance (CAMDR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells[J]. Oncogene,2003,22(16) :2417.
-
9Klees RF,Salasznyk RM,Kingsley K,et al. Laminiw5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway[J]. Mol Biol Cell,2005,16(2) :881.
-
10Gunn WG,Conley A,Deininger L,et al. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6:a potential role in the development of lytic bone disease and tumor progression in multiple myeloma[J]. Stem Cells, 2006,24 (4) : 986.
同被引文献10
-
1Smith DB,Scaffe JH,Eddleston B.The prognostic significance of X-ray changes at presentation and reassessment in patients with multiple myeloma[J].Hematol Oncol,1998,6:1-6.
-
2Abe M.Hyepercalcemia in myeloma[J].Nippon Rinsbo,2007,65:2245-2249.
-
3Zannettino AC,Farrugia AN,Kortesidis A,et al.Elevated serum levels of stromal derived factor-1a lphaare associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients[J].Cancer Res,2005,65:1700-1709.
-
4Yu X,Huang Y,Collin Osdoby P,et al.Stromal cell derived factor 1(SDF-1)recruits osteoclastpre cursors by inducing chemotaxis,matrix metallo proteinase 9(MMP-9) activity,and collagen transmigration[J].J Bone Miner Res,2003,18:1404-1418.
-
5陆再英.内科学[M].北京:人民卫生出版社,2001:155-169
-
6周莉莉,侯健（审校）.骨髓瘤的骨质破坏发生机制研究进展[J].中国实验血液学杂志,2007,15(6):1340-1344. 被引量：5
-
7鲍立,黄晓军.SDF-1/CXCR4与多发性骨髓瘤溶骨性病变的关系[J].中国实验血液学杂志,2008,16(2):442-446. 被引量：4
-
8侯金霞,丁进芳,韩平治,周爱华,田英.多发性骨髓瘤患者特异骨代谢标志物检测及临床应用[J].检验医学,2008,23(4):367-369. 被引量：7
-
9刘爱军,陈文明.骨代谢标志物在多发性骨髓瘤的研究进展[J].中国误诊学杂志,2008,8(30):7319-7321. 被引量：2
-
10李斯丹,徐燕,王亚非,赵耀中,江山,邱录贵.多发性骨髓瘤骨病的临床特点分析[J].中华血液学杂志,2010,31(4):228-232. 被引量：25
-
1张伟,杜成友,徐尔侃.肝癌中P27的表达及其意义[J].重庆医科大学学报,2004,29(4):465-467.
-
2麦凤鸣,梁若斯,胡建波,钟惟德.前列腺癌细胞凋亡相关基因表达及其意义[J].广州医学院学报,2002,30(2):76-78.
-
3宫雪,陈骊珠.整合素与肿瘤侵袭和转移的研究进展[J].现代医药卫生,2007,23(15):2288-2289. 被引量：4
-
4黄玉宝,卿三华,叶长生.结直肠癌生物学基础及其靶点药物治疗研究进展[J].中华胃肠外科杂志,2008,11(3):294-296. 被引量：1
-
5王静,陈亦乐,黄龙兴.外阴癌临床分析及预后因素的探讨[J].中国医师杂志,2004,6(5):680-681. 被引量：1
-
6曹腽,陈晓霞,周彩存.老年晚期非小细胞肺癌治疗进展[J].肿瘤,2015,35(5):579-583. 被引量：32
-
7练斌,杨伟萍,韦长元,覃庆洪,朱非白.老年乳腺癌219例临床特点及治疗对策[J].中华肿瘤防治杂志,2012,19(13):1016-1019. 被引量：13
-
8胡义德.老年非小细胞肺癌的治疗策略[J].第三军医大学学报,2009,31(17):1617-1619. 被引量：1
-
9吴铁球,李可,杨金瑞.前列腺癌发病的危险因素研究现状[J].国外医学（泌尿系统分册）,2003,23(5):519-522. 被引量：7
-
10周彩存,陈晓霞.老年非小细胞肺癌治疗进展[J].老年医学与保健,2008,14(3):135-138. 被引量：3
